上市公司 Propanc Biopharma 计划收购 1 亿美元以太坊
ChainCatcher 消息，生物制药公司 Propanc Biopharma (纳斯达克股票代码: PPCB) 宣布计划在未来 12 个月内收购价值 1 亿美元的以太坊
该公司表示，此举将增强其在加密货币投资、药物开发和资产收购等多方面的企业战略
风险提示 风险提示
关联标签
关联标签
扫码下载
BTC $71,761.39 +0.52%
ETH $2,189.03 +0.16%
BNB $600.54 -0.14%
XRP $1.34 +0.32%
SOL $83.28 +1.08%
TRX $0.3194 +0.76%
DOGE $0.0921 +0.65%
ADA $0.2509 +0.23%
BCH $437.57 -1.18%
LINK $8.93 +1.91%
HYPE $40.67 +3.74%
AAVE $89.81 -0.21%
SUI $0.9335 +2.50%
XLM $0.1550 +0.09%
ZEC $376.47 +18.39% BTC $71,761.39 +0.52% ETH $2,189.03 +0.16% BNB $600.54 -0.14% XRP $1.34 +0.32% SOL $83.28 +1.08% TRX $0.3194 +0.76% DOGE $0.0921 +0.65% ADA $0.2509 +0.23% BCH $437.57 -1.18% LINK $8.93 +1.91% HYPE $40.67 +3.74% AAVE $89.81 -0.21% SUI $0.9335 +2.50% XLM $0.1550 +0.09% ZEC $376.47 +18.39%
风险提示 风险提示
ChainCatcher 与创新者共建Web3世界
